Albert Bourla
Albert Bourla is the CEO of Pfizer, a leading global pharmaceutical company. He gained significant recognition for his leadership during the COVID-19 pandemic, particularly for spearheading the rapid development of the vaccine. Recently, he has indicated Pfizer's focus on oral medications for obesity treatments, acknowledging the company's late entry into the injectable space.
Born on Oct 21, 1961 (64 years old)
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Pfizer CEO Albert Bourla discusses Pfizer’s Q4 adjusted earnings and the competitive landscape for weight-loss drugs on ‘The Claman Countdown.’
6
Taiwan:
Albert Bourla is the CEO of Pfizer who criticized Kennedy’s rhetoric regarding vaccines.
5
Switzerland:
The management, led by Albert Bourla since 2019, has faced criticism for overestimating demand from Covid-19 related businesses.
3
Ireland:
Mr Harris met Pfizer chief executive Albert Bourla in early August to discuss EU reforms.
7
Slovenia:
Albert Bourla is the CEO of Pfizer who was involved in communications with Ursula von der Leyen during the vaccine procurement process.
5
Croatia:
He is the CEO of Pfizer, involved in discussions about vaccine procurement.
5
Pakistan:
Albert Bourla, CEO of Pfizer, has supported Trump's nomination for the Nobel Prize based on the Operation Warp Speed initiative.
6
Spain:
Albert Bourla affirmed that the majority of primary care treatments will be offered with an average savings of 50%.
7
Israel:
Bourla praised Trump for his role in the rapid development of COVID-19 vaccines.
7
Russia:
Albert Bourla is the CEO of Pfizer Inc. who praised Trump's work on COVID-19 vaccine development.
7